RCKT
Rocket Pharmaceuticals Inc
NASDAQ: RCKT · HEALTHCARE · BIOTECHNOLOGY
$3.21
+2.23% today
Updated 2026-07-30
Market cap
$360.34M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.81
Dividend yield
—
52W range
$3 – $5
Volume
2.5M
Rocket Pharmaceuticals Inc (RCKT) Insider transactions
Net insider activity
Net buying (4,336,407 shares)
Buy transactions
55
Sell transactions
45
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-18 | WONG, RODERICK | Director, 10% Owner | Buy | 78,960 | — | — |
| 2026-06-18 | WONG, RODERICK | Director, 10% Owner | Buy | 27,832 | — | — |
| 2026-06-18 | SOUTHWELL, DAVID P | Director | Buy | 64,860 | — | — |
| 2026-06-18 | SOUTHWELL, DAVID P | Director | Buy | 22,862 | — | — |
| 2026-06-18 | MALIK, FADY IBRAHAM | Director | Buy | 64,860 | — | — |
| 2026-06-18 | MALIK, FADY IBRAHAM | Director | Buy | 22,862 | — | — |
| 2026-06-18 | FONG, PETER | Director | Buy | 64,860 | — | — |
| 2026-06-18 | FONG, PETER | Director | Buy | 22,862 | — | — |
| 2026-06-18 | DOLSTEN, MIKAEL | Director | Buy | 64,860 | — | — |
| 2026-06-18 | DOLSTEN, MIKAEL | Director | Buy | 22,862 | — | — |
| 2026-06-18 | BOESS, CARSTEN | Director | Buy | 64,860 | — | — |
| 2026-06-18 | BOESS, CARSTEN | Director | Buy | 22,862 | — | — |
| 2026-05-26 | MILITELLO, JOHN | See Remarks | Buy | 51,509 | — | — |
| 2026-05-26 | MILITELLO, JOHN | See Remarks | Sale | 49,798 | — | — |
| 2026-05-26 | MILITELLO, JOHN | See Remarks | Sale | 28,910 | — | — |
| 2026-05-26 | MILITELLO, JOHN | See Remarks | Sale | 27,003 | — | — |
| 2026-05-26 | MILITELLO, JOHN | See Remarks | Buy | 24,899 | — | — |
| 2026-05-26 | MILITELLO, JOHN | See Remarks | Sale | 24,545 | — | — |
| 2026-05-26 | MILITELLO, JOHN | See Remarks | Sale | 20,000 | — | — |
| 2026-05-26 | MILITELLO, JOHN | See Remarks | Sale | 18,000 | — | — |
| 2026-05-26 | MILITELLO, JOHN | See Remarks | Buy | 16,061 | — | — |
| 2026-05-26 | MILITELLO, JOHN | See Remarks | Buy | 15,002 | — | — |
| 2026-05-26 | MILITELLO, JOHN | See Remarks | Sale | 10,000 | — | — |
| 2026-05-26 | MILITELLO, JOHN | See Remarks | Buy | 9,091 | — | — |
| 2026-05-26 | MILITELLO, JOHN | See Remarks | Sale | 2,000 | — | — |
| 2026-05-21 | SHAH, GAURAV | CEO | Sale | 76,490 | $1.69 | $129344.59 |
| 2026-05-21 | SHAH, GAURAV | CEO | Buy | 76,490 | $1.69 | $129344.59 |
| 2026-05-21 | SHAH, GAURAV | CEO | Sale | 55,684 | $3.09 | $171840.82 |
| 2026-05-19 | WILSON, MARTIN | General Counsel | Sale | 662 | $3.01 | $1995.27 |
| 2026-05-19 | SHAH, GAURAV | CEO | Sale | 2,409 | $3.01 | $7260.73 |
| 2026-05-19 | MILITELLO, JOHN | See Remarks | Sale | 384 | $3.01 | $1157.38 |
| 2026-05-13 | WILSON, MARTIN | General Counsel | Sale | 3,361 | $3.61 | $12119.77 |
| 2026-05-13 | SHAH, GAURAV | CEO | Sale | 2,728 | $3.61 | $9837.17 |
| 2026-05-13 | MILITELLO, JOHN | See Remarks | Sale | 855 | $3.61 | $3083.13 |
| 2026-05-07 | CHAUDHURI, SARBANI | See Remarks | Sale | 17,650 | $3.84 | $67740.70 |
| 2026-02-18 | WILSON, MARTIN | General Counsel | Sale | 1,376 | $3.34 | $4593.09 |
| 2026-02-18 | SHAH, GAURAV | CEO | Sale | 5,990 | $3.34 | $19994.62 |
| 2026-02-18 | MILITELLO, JOHN | See Remarks | Sale | 1,157 | $3.34 | $3862.07 |
| 2026-02-13 | WILSON, MARTIN | General Counsel | Sale | 12,253 | $3.31 | $40581.94 |
| 2026-02-13 | SHAH, GAURAV | CEO | Sale | 12,279 | $3.31 | $40668.05 |
| 2026-02-13 | MILITELLO, JOHN | See Remarks | Sale | 3,726 | $3.31 | $12340.51 |
| 2026-02-11 | WILSON, MARTIN | General Counsel | Buy | 468,187 | — | — |
| 2026-02-11 | WILSON, MARTIN | General Counsel | Buy | 311,813 | — | — |
| 2026-02-11 | STEVENS, CHRISTOPHER JAMES | Chief Operating Officer | Buy | 93,037 | — | — |
| 2026-02-11 | STEVENS, CHRISTOPHER JAMES | Chief Operating Officer | Buy | 61,963 | — | — |
| 2026-02-11 | SHAH, GAURAV | CEO | Buy | 870,648 | — | — |
| 2026-02-11 | SHAH, GAURAV | CEO | Buy | 286,028 | — | — |
| 2026-02-11 | RIZVI, SYED ALI-AAMIR | Chief Medical Officer | Buy | 93,037 | — | — |
| 2026-02-11 | RIZVI, SYED ALI-AAMIR | Chief Medical Officer | Buy | 61,963 | — | — |
| 2026-02-11 | MILITELLO, JOHN | See Remarks | Buy | 45,018 | — | — |
| 2026-02-11 | MILITELLO, JOHN | See Remarks | Buy | 29,982 | — | — |
| 2026-02-11 | CHAUDHURI, SARBANI | See Remarks | Buy | 189,076 | — | — |
| 2026-02-11 | CHAUDHURI, SARBANI | See Remarks | Buy | 125,924 | — | — |
| 2026-01-02 | BJORK, ELISABETH | Director | Buy | 10,000 | $3.44 | $34400.00 |
| 2025-11-18 | WILSON, MARTIN | General Counsel | Sale | 1,646 | $2.98 | $4910.02 |
| 2025-11-18 | SHAH, GAURAV | Director, CEO | Sale | 6,276 | $2.98 | $18721.31 |
| 2025-11-18 | SCHWARTZ, JONATHAN DAVID | See Remarks | Sale | 2,545 | $2.98 | $7591.74 |
| 2025-11-18 | MILITELLO, JOHN | See Remarks | Sale | 1,086 | $2.98 | $3239.54 |
| 2025-11-03 | WILSON, MARTIN | General Counsel | Buy | 100,000 | — | — |
| 2025-10-14 | MILITELLO, JOHN | See Remarks | Sale | 19,841 | $3.96 | $78570.36 |
| 2025-10-14 | MILITELLO, JOHN | See Remarks | Sale | 5,514 | $3.97 | $21863.01 |
| 2025-10-14 | MILITELLO, JOHN | See Remarks | Sale | 3,005 | $3.97 | $11929.85 |
| 2025-10-14 | MILITELLO, JOHN | See Remarks | Sale | 558 | $3.98 | $2218.05 |
| 2025-10-06 | RIZVI, SYED ALI-AAMIR | Chief Medical Officer | Buy | 383,854 | — | — |
| 2025-10-06 | RIZVI, SYED ALI-AAMIR | Chief Medical Officer | Buy | 283,018 | — | — |
| 2025-10-06 | RIZVI, SYED ALI-AAMIR | Chief Medical Officer | Buy | 62,893 | — | — |
| 2025-09-24 | FONG, PETER | Director | Buy | 30,000 | — | — |
| 2025-09-24 | FONG, PETER | Director | Buy | 23,333 | — | — |
| 2025-09-19 | RTW, INVESTMENTS, LP | Director, 10% Owner, See remarks | Sale | 1 | — | — |
| 2025-09-19 | RTW, INVESTMENTS, LP | Director, 10% Owner, See remarks | Sale | 1,000,000 | $3.11 | $3.10M |
| 2025-09-19 | RTW, INVESTMENTS, LP | Director, 10% Owner, See remarks | Sale | 59,000 | $3.11 | $183195.00 |
| 2025-09-19 | RTW, INVESTMENTS, LP | Director, 10% Owner, See remarks | Buy | 41,000 | $19.09 | $782755.60 |
| 2025-09-08 | WILSON, MARTIN | General Counsel | Buy | 150,000 | — | — |
| 2025-09-08 | SCHWARTZ, JONATHAN DAVID | See Remarks | Buy | 80,000 | — | — |
| 2025-09-08 | MILITELLO, JOHN | See Remarks | Buy | 40,000 | — | — |
| 2025-08-27 | BJORK, ELISABETH | Director | Buy | 10,000 | $3.41 | $34100.00 |
| 2025-08-19 | WILSON, MARTIN | General Counsel | Sale | 588 | $3.00 | $1761.65 |
| 2025-08-19 | SCHWARTZ, JONATHAN DAVID | See Remarks | Sale | 805 | $3.00 | $2411.78 |
| 2025-08-19 | MILITELLO, JOHN | See Remarks | Sale | 361 | $3.00 | $1081.56 |
| 2025-08-18 | WILSON, MARTIN | General Counsel | Sale | 1,004 | $3.07 | $3077.26 |
| 2025-08-18 | SHAH, GAURAV | Director, CEO | Sale | 2,234 | $3.05 | $6813.70 |
| 2025-08-18 | SCHWARTZ, JONATHAN DAVID | See Remarks | Sale | 1,680 | $3.07 | $5149.20 |
| 2025-08-18 | MILITELLO, JOHN | See Remarks | Sale | 699 | $3.07 | $2142.43 |
| 2025-08-14 | WILSON, MARTIN | General Counsel | Sale | 12,109 | $3.02 | $36557.07 |
| 2025-08-14 | SCHWARTZ, JONATHAN DAVID | See Remarks | Sale | 11,161 | $3.02 | $33695.06 |
| 2025-08-14 | MILITELLO, JOHN | See Remarks | Sale | 7,043 | $3.02 | $21262.82 |
| 2025-08-04 | STEVENS, CHRISTOPHER JAMES | Chief Operating Officer | Buy | 554,071 | — | — |
| 2025-08-04 | STEVENS, CHRISTOPHER JAMES | Chief Operating Officer | Buy | 407,166 | — | — |
| 2025-07-03 | ONDREY, AARON | Chief Financial Officer | Sale | 1,477 | $2.88 | $4256.71 |
| 2025-06-18 | WONG, RODERICK | Director, 10% Owner | Buy | 30,000 | — | — |
| 2025-06-18 | WONG, RODERICK | Director, 10% Owner | Buy | 17,667 | — | — |
| 2025-06-18 | SOUTHWELL, DAVID P | Director | Buy | 30,000 | — | — |
| 2025-06-18 | PRATUMSUWAN, PIRATIP | Director | Buy | 30,000 | — | — |
| 2025-06-18 | MALIK, FADY IBRAHAM | Director | Buy | 30,000 | — | — |
| 2025-06-18 | MAKKER, GOTHAM | Director | Buy | 30,000 | — | — |
| 2025-06-18 | MAKKER, GOTHAM | Director | Buy | 19,434 | — | — |
| 2025-06-18 | GRANADILLO, PEDRO P | Director | Buy | 30,000 | — | — |
| 2025-06-18 | GRANADILLO, PEDRO P | Director | Buy | 24,734 | — | — |
| 2025-06-18 | DOLSTEN, MIKAEL | Director | Buy | 30,000 | — | — |
| 2025-06-18 | BOESS, CARSTEN | Director | Buy | 30,000 | — | — |
Frequently asked questions
Are RCKT insiders buying or selling?
Over the transactions on record, RCKT insiders have been net buyers, with about $4.08M in stock sold across 45 sales, against 4 open-market purchases.
Does insider selling at RCKT mean the stock will fall?
Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.
Which RCKT insiders are selling the most?
Recent selling is concentrated in a few names. RTW, INVESTMENTS, LP accounts for the largest share on record, with about $3.29M sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.